radiation sensitivity cells isolated directly surgical specimens primary tumor distant metastases different melanoma patients measured vitro using courtenay soft agar colony assay curves fitted cell survival data method squares using hit models patients divided distinct groups group consisted patients radioresistant primary tumors d0s NUMBER NUMBER gy NUMBER NUMBER gy radiation sensitivity metastases d0s NUMBER NUMBER gy NUMBER NUMBER gy significantly different primary tumor group heterogeneity observed group ii consisted patients radiosensitive primary tumors d0s NUMBER NUMBER gy NUMBER NUMBER gy heterogeneity observed group metastases radiosensitive d0s NUMBER NUMBER gy NUMBER NUMBER gy group iii consisted patients heterogeneous disease primary tumor patients group radiosensitive d0s NUMBER NUMBER gy NUMBER NUMBER gy radioresistant metastasis patient significantly p NUMBER resistant d0s NUMBER NUMBER gy NUMBER NUMBER gy primary tumor metastases significantly radiosensitive primary tumor patient observations suggest progression tumors increased levels malignancy includes increased ability radioresistant speculated similar genomic alterations responsible development metastatic radioresistant tumor cell phenotype severe implications treatment metastatic malignant melanoma low linear energy transfer ionizing radiation development predictive assays tumor treatment sensitivity dose response multitarget single linear quadratic